Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of MRI Based Functional Imaging for the Evaluation of Bone Metastasis in Men With Castrate Resistant Prostate Cancer Receiving XL184

NCT01599793 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT01599793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of MRI Based Functional Imaging for the Evaluation of Bone Metastasis in Men With Castrate Resistant Prostate Cancer Receiving XL184
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, castrate-resistant prostate cancer, recurrent prostate cancer, stage iv prostate cancer